Actively Recruiting

Age: 18Years - 130Years
All Genders
NCT06767462

An Ophthalmic Safety Study in Patients With Breast Cancer

Led by AstraZeneca · Updated on 2025-07-23

160

Participants Needed

75

Research Sites

122 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To assess ophthalmic health in parallel cohorts of patients with breast cancer

CONDITIONS

Official Title

An Ophthalmic Safety Study in Patients With Breast Cancer

Who Can Participate

Age: 18Years - 130Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent in the qualifying study
  • Signed informed consent in the ophthalmic study prior to any ophthalmic assessments or procedures
  • Completed the baseline ophthalmic examination before the first dose in the qualifying study
  • Meets all eligibility criteria in the qualifying study
Not Eligible

You will not qualify if you...

  • Not randomized or not receiving assigned treatment in a qualifying study
  • Contraindications to any ophthalmic procedure required by the study or allergy to pupil dilating agents
  • Investigator judgement that the patient is unlikely to comply with study procedures, restrictions, or requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 75 locations

1

Research Site

La Jolla, California, United States, 92093

Not Yet Recruiting

2

Research Site

Palo Alto, California, United States, 94304

Not Yet Recruiting

3

Research Site

San Diego, California, United States, 92123

Withdrawn

4

Research Site

Iowa City, Iowa, United States, 52242

Actively Recruiting

5

Research Site

New York, New York, United States, 10029

Not Yet Recruiting

6

Research Site

Winston-Salem, North Carolina, United States, 27104

Not Yet Recruiting

7

Research Site

Cleveland, Ohio, United States, 44195

Not Yet Recruiting

8

Research Site

Clairton, Pennsylvania, United States, 15025

Suspended

9

Research Site

Pittsburgh, Pennsylvania, United States, 15219

Actively Recruiting

10

Research Site

Sioux Falls, South Dakota, United States, 57105

Not Yet Recruiting

11

Research Site

Bartlett, Tennessee, United States, 38133

Not Yet Recruiting

12

Research Site

Houston, Texas, United States, 77030

Not Yet Recruiting

13

Research Site

Buenos Aires, Argentina, C1125ABD

Not Yet Recruiting

14

Research Site

Buenos Aires, Argentina, C1425AYC

Withdrawn

15

Research Site

CABA, Argentina, C1061

Not Yet Recruiting

16

Research Site

Córdoba, Argentina, 5008

Not Yet Recruiting

17

Research Site

San Miguel de Tucumán, Argentina, 4000

Not Yet Recruiting

18

Research Site

San Miguel de Tucumán, Argentina, T4000IAK

Not Yet Recruiting

19

Research Site

Edegem, Belgium, 2650

Not Yet Recruiting

20

Research Site

Leuven, Belgium, 3000

Actively Recruiting

21

Research Site

Liège, Belgium, 4000

Actively Recruiting

22

Research Site

Alfenas, Brazil, 37130-000

Not Yet Recruiting

23

Research Site

Belo Horizonte, Brazil, 30130-100

Not Yet Recruiting

24

Research Site

Curitiba, Brazil, 80810-050

Not Yet Recruiting

25

Research Site

Lajeado, Brazil, 95900000

Not Yet Recruiting

26

Research Site

Porto Alegre, Brazil, 90035-001

Not Yet Recruiting

27

Research Site

Porto Alegre, Brazil, 90050-170

Not Yet Recruiting

28

Research Site

Pouso Alegre, Brazil, 37554-216

Not Yet Recruiting

29

Research Site

Rio de Janeiro, Brazil, 20560-120

Not Yet Recruiting

30

Research Site

São Paulo, Brazil, 01321-001

Not Yet Recruiting

31

Research Site

Sorocaba, Brazil, 18060-105

Not Yet Recruiting

32

Research Site

Três Lagoas, Brazil, 79601-001

Not Yet Recruiting

33

Research Site

Vitória, Brazil, 29055-450

Not Yet Recruiting

34

Research Site

Montreal, Quebec, Canada, H2X 3E4

Not Yet Recruiting

35

Research Site

Montreal, Quebec, Canada, H4A 3J1

Not Yet Recruiting

36

Research Site

Santiago, Chile, 7500587

Not Yet Recruiting

37

Research Site

Santiago, Chile, 7620157

Not Yet Recruiting

38

Research Site

Santiago, Chile, 8331143

Withdrawn

39

Research Site

Bordeaux Cédex, France, 33077

Not Yet Recruiting

40

Research Site

Caen, France, 14000

Not Yet Recruiting

41

Research Site

Nantes, France, 44202

Withdrawn

42

Research Site

Poitiers, France, 86021

Not Yet Recruiting

43

Research Site

Suresnes, France, 92151

Not Yet Recruiting

44

Research Site

Ashdod, Israel, 7747629

Actively Recruiting

45

Research Site

Nahariya, Israel, 2210001

Not Yet Recruiting

46

Research Site

Milan, Italy, 20132

Not Yet Recruiting

47

Research Site

Aguascalientes, Mexico, 20230

Withdrawn

48

Research Site

Mexico City, Mexico, 03810

Withdrawn

49

Research Site

San Pedro Garza García, Mexico, 66220

Withdrawn

50

Research Site

Veracruz, Mexico, 91851

Withdrawn

51

Research Site

Lodz, Poland, 90-302

Not Yet Recruiting

52

Research Site

Nowa Sól, Poland, 67-106

Not Yet Recruiting

53

Research Site

Amadora, Portugal, 2720-276

Not Yet Recruiting

54

Research Site

Braga, Portugal, 4710-243

Not Yet Recruiting

55

Research Site

Lisbon, Portugal, 1998-018

Withdrawn

56

Research Site

Busan, South Korea, 48108

Withdrawn

57

Research Site

Daegu, South Korea, 41931

Withdrawn

58

Research Site

Seoul, South Korea, 6351

Not Yet Recruiting

59

Research Site

Badalona, Spain, 08003

Actively Recruiting

60

Research Site

Barcelona, Spain, 08028

Actively Recruiting

61

Research Site

Barcelona, Spain, 08035

Actively Recruiting

62

Research Site

Barcelona, Spain, 08036

Not Yet Recruiting

63

Research Site

Girona, Spain, 17007

Not Yet Recruiting

64

Research Site

L'Hospitalet de Llobregat, Spain, 08908

Not Yet Recruiting

65

Research Site

Leganés, Spain, 28911

Not Yet Recruiting

66

Research Site

Madrid, Spain, 28007

Actively Recruiting

67

Research Site

Madrid, Spain, 28009

Not Yet Recruiting

68

Research Site

Madrid, Spain, 28033

Actively Recruiting

69

Research Site

Madrid, Spain, 28034

Actively Recruiting

70

Research Site

Madrid, Spain, 28040

Actively Recruiting

71

Research Site

Madrid, Spain, 28041

Not Yet Recruiting

72

Research Site

Madrid, Spain, 28050

Actively Recruiting

73

Research Site

Majadahonda, Spain, 28222

Actively Recruiting

74

Research Site

Salamanca, Spain, 37007

Not Yet Recruiting

75

Research Site

Sant Joan Despí, Spain, 08970

Not Yet Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

An Ophthalmic Safety Study in Patients With Breast Cancer | DecenTrialz